Related references
Note: Only part of the references are listed.Theranostic Design of Angiopep-2 Conjugated Hyaluronic Acid Nanoparticles (Thera-ANG-cHANPs) for Dual Targeting and Boosted Imaging of Glioma Cells
Angela Costagliola di Polidoro et al.
CANCERS (2021)
A Microfluidic Platform to design Multimodal PEG - crosslinked Hyaluronic Acid Nanoparticles (PEG-cHANPs) for diagnostic applications
Olimpia Tammaro et al.
SCIENTIFIC REPORTS (2020)
Future perspectives of nanoparticle-based contrast agents for cardiac magnetic resonance in myocardial infarction
Anna Maria Grimaldi et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2019)
Emerging techniques in atherosclerosis imaging
Maaz B. J. Syed et al.
BRITISH JOURNAL OF RADIOLOGY (2019)
Water-Mediated Nanostructures for Enhanced MRI: Impact of Water Dynamics on Relaxometric Properties of Gd-DTPA
Franca De Sarno et al.
THERANOSTICS (2019)
Vulnerable Plaque, Characteristics, Detection, and Potential Therapies
Anouar Hafiane
JOURNAL OF CARDIOVASCULAR DEVELOPMENT AND DISEASE (2019)
Emerging Use of Nanoparticles in Diagnosis Of Atherosclerosis Disease: A Review
Franca De Sarno et al.
NANOINNOVATION 2017 (2018)
PEGylated crosslinked hyaluronic acid nanoparticles designed through a microfluidic platform for nanomedicine
Maria Russo et al.
NANOMEDICINE (2017)
Hydrodenticity to enhance relaxivity of gadolinium-DTPA within crosslinked hyaluronic acid nanoparticles
Maria Russo et al.
NANOMEDICINE (2017)
Hyaluronan Nanoparticles Selectively Target Plaque-Associated Macrophages and Improve Plaque Stability in Atherosclerosis
Thijs J. Beldman et al.
ACS NANO (2017)
Vascular-targeted nanocarriers: design considerations and strategies for successful treatment of atherosclerosis and other vascular diseases
William J. Kelley et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2016)
A Microfluidic Platform to design crosslinked Hyaluronic Acid Nanoparticles (cHANPs) for enhanced MRI
Maria Russo et al.
SCIENTIFIC REPORTS (2016)
Non-invasive molecular imaging of vulnerable atherosclerotic plaques
Marco Magnoni et al.
JOURNAL OF CARDIOLOGY (2015)
Nanoparticles functionalised with an anti-platelet human antibody for in vivo detection of atherosclerotic plaque by magnetic resonance imaging
Marie-Josee Jacobin-Valat et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2015)
Active targeting of early and mid-stage atherosclerotic plaques using self-assembled peptide amphiphile micelles
Laurie B. Mlinar et al.
BIOMATERIALS (2014)
Imaging of the Carotid Artery Vulnerable Plaque
Luca Saba et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2014)
CD36, a scavenger receptor implicated in atherosclerosis
Young Mi Park
EXPERIMENTAL AND MOLECULAR MEDICINE (2014)
Cholesterol Crystals and Inflammation
Alena Grebe et al.
CURRENT RHEUMATOLOGY REPORTS (2013)
Altered expression of inflammation-related genes in human carotid atherosclerotic plaques
Maria Donata Di Taranto et al.
ATHEROSCLEROSIS (2012)
Macrophages in the Pathogenesis of Atherosclerosis
Kathryn J. Moore et al.
CELL (2011)
Progress and challenges in translating the biology of atherosclerosis
Peter Libby et al.
NATURE (2011)
The BioImage Study: Novel approaches to risk assessment in the primary prevention of atherosclerotic cardiovascular disease-study design and objectives
Pieter Muntendam et al.
AMERICAN HEART JOURNAL (2010)
Macrophage-Specific Lipid-Based Nanoparticles Improve Cardiac Magnetic Resonance Detection and Characterization of Human Atherosclerosis
Michael J. Lipinski et al.
JACC-CARDIOVASCULAR IMAGING (2009)
Advances in detection and characterization of atherosclerosis using contrast agents targeting the macrophage
Michael J. Lipinski et al.
JOURNAL OF NUCLEAR CARDIOLOGY (2006)
Quantification of human atherosclerotic plaques using spatially enhanced cluster analysis of multicontrast-weighted magnetic resonance images
VV Itskovich et al.
MAGNETIC RESONANCE IN MEDICINE (2004)
Share Paper
